Accuity Delivery Systems, LLC

Accuity Delivery Systems, LLC specializes in enhancing clinical documentation integrity and optimizing revenue cycle management for healthcare providers, ensuring compliance and maximizing reimbursement. Accuity Delivery Systems, LLC, founded in 2016, is based in New York, US. The company focuses on improving clinical documentation through its advanced technology solutions. In October 2020, it underwent a significant ownership change when 22C Capital and Frazier Healthcare Partners acquired the company from WindRose Health Investors, with undisclosed financial terms.

Todd Van Meter serves as the CEO, leading the company through its strategic initiatives. Accuity specializes in clinical documentation integrity and revenue cycle management solutions, primarily through its flagship product, the Amplifi Clinical Data Platform. This platform utilizes advanced technology to enhance clinical documentation accuracy and compliance, ensuring that healthcare providers receive optimal reimbursement for the services rendered. The company’s offerings are designed to address the challenges of revenue capture in healthcare systems, optimizing the financial performance of hospitals by bridging the gap between the care delivered and the revenue received.

Accuity serves a diverse client base, including hospitals and health systems across various geographical markets in the United States, leveraging insights from the review of over 5 million medical charts and the expertise of more than 750 clinical professionals. The solutions aim to improve documentation quality and facilitate ongoing education for physicians and coding specialists, ultimately enhancing patient care and organizational efficiency. Accuity generates revenue through a combination of subscription-based services and partnerships with healthcare institutions. The company's financial model typically involves agreements where clients engage Accuity for its clinical documentation services, allowing healthcare organizations to improve their revenue cycle management without upfront costs.

Clients may initially participate in a 60-day proof-of-concept pilot, which serves to validate the potential impact of Accuity’s solutions before committing to a longer-term contract. Revenue generated from these engagements is tied to the net cash benefits realized through improved documentation accuracy and compliance, which in the past year has exceeded USD 600 mn for its clients. The company's pricing structure is reflective of the value delivered through its proprietary technology and clinical expertise, fostering sustainable relationships in the healthcare sector. In the future, Accuity plans to develop additional products to enhance its service offerings, though specific product details and release dates have not been disclosed.

The company is also targeting expansion into new geographical regions to broaden its client base and improve service delivery. The most recent funding round in October 2020, amounting to USD 25. 50 mn, will be utilized to support these initiatives, helping enhance its technology and expand market reach.